title: Characterization of a new spontaneously developed murine mammary adenocarcinoma in syngeneic BALB/c hosts.
abstract: A mouse mammary tumor cell line, designated JC, has been established from a spontaneously developed primary adenocarcinoma of an aged virgin female BALB/c mouse. Isoenzyme analyses including glucose-6-phosphate dehydrogenase, lactate dehydrogenase, and peptidase proved that this cell line is of murine origin and devoid of contamination from other species. Karyotyping revealed that the number of chromosome ranged from 26 to 100, with a modal number of 40. Electron microscopic examination detected the presence of tonofilament and desmosomes confirming its epithelial nature. In addition, no type B or C virus particle was detected, although intracysternal A particle was observed occasionally. Tumorigenicity in immunocompetent syngeneic hosts was easily established by s.c., i.p., and i.v. injection of viable JC tumor cells. A very weak immunogenicity of the JC tumor was demonstrated through its immunization-challenging on syngeneic immunocompetent hosts. Although no rejection of JC tumor was noted, a significant prolongation for the incubation period before an obvious and palpable tumor growth was detected between the experimental and the control animals. Development of a concomitant immunity was also detected. The JC tumor represents a valuable murine mammary tumor model which is different from other available models because of its unique origin, absence of virus particles, very weak immunogenicity, and high tumorigenicity in syngeneic hosts. The cell line has been maintained for more than 5 yr and has been used for experimental immunotherapy in our laboratory.
authors.affiliation: Department of Diagnostic Immunology Research and Biochemistry, Roswell Park Memorial Institute, Buffalo, New York 14263.
authors.forename: T Y
authors.initials: TY
authors.lastname: Chao
authors.forename: T M
authors.initials: TM
authors.lastname: Chu
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D002455:Cell Division; D004848:Epithelium / Q000473:pathology; D005260:Female; D005620:Freund's Adjuvant; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D007114:Immunization; D007527:Isoenzymes; D007621:Karyotyping; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D010447:Peptide Hydrolases / Q000032:analysis; D011425:Propionibacterium acnes / Q000276:immunology; D014407:Tumor Cells, Cultured; D014771:Virion / Q000648:ultrastructure
chemical_list: D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D007527:Isoenzymes; D005620:Freund's Adjuvant; D007770:L-Lactate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D010447:Peptide Hydrolases